Looking for a lottery ticket? Check out OVIT their ceo's last company, Ilex Oncology, Genzyme bought for $1 billion. Oncovista is going from undiscovered to blockbuster with their oncology drug pipeline. www.oncovista.com
The only problem with 28cent stocks is the possibility of dilution. Cheap stocks always looking for more money and volume is usually low until the co. announces a FDA approved drug. U R correct, it's a lottery ticket, but I'll track it. THX, BG70